Annual report [Section 13 and 15(d), not S-K Item 405]

LOSS PER SHARE

v3.25.0.1
LOSS PER SHARE
12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
LOSS PER SHARE LOSS PER SHARE
Loss per share computations are based upon the following table:
(In thousands, except per share data) 2024 2023 2022
Net Loss $ (16,215) $ (26,421) $ (35,747)
Basic Earnings Weighted Average Shares 35,037  33,104  32,164 
Net Effect of Dilutive Stock Options —  —  — 
Diluted Earnings Weighted Average Shares 35,037  33,104  32,164 
Basic Loss Per Share $ (0.46) $ (0.80) $ (1.11)
Diluted Loss Per Share $ (0.46) $ (0.80) $ (1.11)
Stock options with exercise prices greater than the average market price of the underlying common shares are excluded from the computation of diluted earnings per share because they are out-of-the-money and the effect of their inclusion would be anti-dilutive. The Company includes the dilutive effect of shares issuable upon conversion of its Convertible Notes in the calculation of diluted income per share using the if-converted method. The Company has the option for the Convertible Notes to settle the conversion value in any combination of cash or shares, and as such, the maximum number of shares issuable are included in the dilutive share count if the effect would be dilutive. The Company incurred a net loss for the years ended December 31, 2024, 2023, and 2022, therefore all outstanding stock options, unvested restricted stock units and the effect of the Convertible Notes are excluded from the computation of diluted loss per share because the effect of their inclusion would be antidilutive.
Antidilutive shares excluded from diluted loss per share computations were as follows:
(In thousands) 2024 2023 2022
Stock Options and Unvested RSUs 1,040  767  1,380 
Convertible Notes 553  —  — 
Total Antidilutive Securities 1,593  767  1,380 
The Company funded substantially all of its 2023 and a portion of its 2024 401K contributions outstanding with treasury stock in lieu of cash, and returned to cash contributions in the second quarter of 2024. The earnings per share computations for the year ended December 31, 2023 are inclusive of approximately 0.1 million in shares outstanding for the equivalent shares needed to fulfill the period’s 401K obligation using the closing share price as of December 31, 2023.